Erratum: Applying linear and non-linear methods for parallel prediction of volume of distribution and fraction of unbound drug (PLoS ONE 8: 10 (e74758) DOI: 10.1371/journal.pone.0074758);Applying Linear and Non-Linear Methods for Parallel Prediction of Volume of Distribution and Fraction of Unbound Drug

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  del Amo, Eva M ^a   Ghemtio, Leo ^a   Xhaard, Henri ^a   Yliperttula, Marjo ^a   Urtti, Arto ^a   Kidron, Heidi ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; AREA UNDER THE CURVE; ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; DRUG DISTRIBUTION; FRACTION UNBOUND; HYDROPHILICITY; LINEAR PARTIAL LEAST SQUARE REGRESSION; LIPOPHILICITY; MULTIVARIATE ANALYSIS; NON LINEAR RECURSIVE PARTITIONING; PHARMACOLOGICAL PARAMETERS; PHYSICAL CHEMISTRY; PREDICTION; PRINCIPAL COMPONENT ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SOLUBILITY; STATISTICAL PARAMETERS;

LINEAR MODELS; MODELS, BIOLOGICAL; NONLINEAR DYNAMICS; PHARMACOKINETICS; TISSUE DISTRIBUTION;

EID: 84885031488     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0141943     Document Type: Erratum

References (38)

1. Lim VS, (1991) Recombinant human erythropoietin in predialysis patients. Am J Kidney Dis 18: 34-37.
2. Tett SE, Cutler DJ, Day RO, Brown KF, (1988) A dose-ranging study of the pharmacokinetics of hydroxy-chloroquine following intravenous administration to healthy volunteers. Br J Clin Pharmacol 26: 303-313.
3. Paul Y, Dhake AS, Parle M, Singh B, (2010) In Silico Quantitative Structure Pharmacokinetic Relationship Modeling for Quinolone Drugs: Biological Half-Life. 22: 4880-4890.
4. Gleeson MP, Waters NJ, Paine SW, Davis AM, (2006) In silico human and rat Vss quantitative structure-activity relationship models. J Med Chem 49: 1953-1963.
5. Hirono S, Nakagome I, Hirano H, Yoshii F, Moriguchi I, (1994) Non-congeneric structure-pharmacokinetic property correlation studies using fuzzy adaptive least-squares: volume of distribution. Biol Pharm Bull 17: 686-690.
6. Karalis V, Tsantili-Kakoulidou A, Macheras P, (2002) Multivariate statistics of disposition pharmacokinetic parameters for structurally unrelated drugs used in therapeutics. Pharm Res 19: 1827-1834.
7. Karalis V, Tsantili-Kakoulidou A, Macheras P, (2003) Quantitative structure-pharmacokinetic relationships for disposition parameters of cephalosporins. 20: 115-123.
8. Lombardo F, Obach RS, Dicapua FM, Bakken GA, Lu J, et al. (2006) A hybrid mixture discriminant analysis-random forest computational model for the prediction of volume of distribution of drugs in human. J Med Chem 49: 2262-2267.
9. Ng C, Xiao Y, Putnam W, Lum B, Tropsha A, (2004) Quantitative structure-pharmacokinetic parameters relationships (QSPKR) analysis of antimicrobial agents in humans using simulated annealing k-nearest-neighbor and partial least-square analysis methods. J Pharm Sci 93: 2535-2544.
10. Turner JV, Maddalena DJ, Cutler DJ, (2004) Pharmacokinetic parameter prediction from drug structure using artificial neural networks. Int J Pharm 270: 209-219.
11. Balakin KV, Ivanenkov YA, Savchuk NP, Ivashchenko AA, Ekins S, (2005) Comprehensive computational assessment of ADME properties using mapping techniques. Curr Drug Discov Technol 2: 99-113.
12. Berellini G, Springer C, Waters NJ, Lombardo F, (2009) In silico prediction of volume of distribution in human using linear and nonlinear models on a 669 compound data set. J Med Chem 52: 4488-4495.
13. Fatemi MH, Ghorbannezhad Z, (2011) Estimation of the volume of distribution of some pharmacologically important compounds from their structural descriptors. 76: 1003-1014.
14. Demir-Kavuk O, Bentzien J, Muegge I, Knapp E, (2011) DemQSAR: predicting human volume of distribution and clearance of drugs. J Comput Aided Mol Des 25: 1121-1133.
15. Zhivkova Z, Doytchinova I, (2012) Prediction of steady-state volume of distribution of acidic drugs by quantitative structure-pharmacokinetics relationships. J Pharm Sci 101: 1253-1266.
16. Gombar VK, Hall SD (2013) Quantitative Structure-Activity Relationship Models of Clinical Pharmacokinetics: Clearance and Volume of Distribution. J Chem Inf Model.
17. Cruciani G, Crivori P, Carrupt P, Testa B, (2000) Molecular fields in quantitative structure-permeation relationships: the VolSurf approach. 503: 17-30.
18. Obach RS, Lombardo F, Waters NJ, (2008) Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 670 Drug Compounds. Drug Metab Dispos 36: 1385-1405.
19. Gleeson MP, (2007) Plasma protein binding affinity and its relationship to molecular structure: an in-silico analysis. J Med Chem 50: 101-112.
20. Moda TL, Montanari CA, Andricopulo AD, (2007) Hologram QSAR model for the prediction of human oral bioavailability. Bioorg Med Chem 15: 7738-7745.
21. Ma CY, Yang SY, Zhang H, Xiang ML, Huang Q, et al. (2008) Prediction models of human plasma protein binding rate and oral bioavailability derived by using GA-CG-SVM method. J Pharm Biomed Anal 47: 677-682.
22. ACD/Dictionary, Advanced Chemistry Development, Inc., Toronto, On, Canada. Available: www.acdlabs.com.
23. SYBYL 8.0, Tripos International, St. Louis, Missouri, USA.
24. White NJ, (1994) Clinical pharmacokinetics and pharmacodynamics of artemisinin and derivatives. Trans R Soc Trop Med Hyg 88Suppl 1: S41-3.
25. Watts NB, Diab DL, (2010) Long-term use of bisphosphonates in osteoporosis. J Clin Endocrinol Metab 95: 1555-1565.
26. ACDlabs software, Advanced Chemistry Development, Inc., Toronto, On, Canada. Available: www.acdlabs.com.
27. MOE, Molecular Operating Environment, Chemical Computing Group: Montreal, Canada, 2008.
28. SIMCAplus software, Umetrics AB, Box 7960, SE-90719 Umeå, Sweden.
29. Chen C, Liaw A, Breiman L (2004) Using Random Forest to Learn Imbalanced Data. Technical report 666, Department of Statistics, University of Berkeley.
30. Hand DJ, Till RJ, (2001) A Simple Generalisation of the Area Under the ROC Curve for Multiple Class Classification Problems. Machine Learning 45: 171-186.
31. Tropsha A, Gramatica P, Gombar VK, (2003) The Importance of Being Earnest: Validation is the Absolute Essential for Successful Application and Interpretation of QSPR Models. 22: 69-77.
32. Zhang S, Golbraikh A, Oloff S, Kohn H, Tropsha A, (2006) A Novel Automated Lazy Learning QSAR (ALL-QSAR) Approach: Method Development, Applications, and Virtual Screening of Chemical Databases Using Validated ALL-QSAR Models. 46: 1984-1995.
33. Suite 2012: Maestro (2012) version 9.3, Schrödinger, LLC, New York, NY.
34. Strobl C, Boulesteix AL, Zeileis A, Hothorn T, (2007) Bias in random forest variable importance measures: illustrations, sources and a solution. BMC Bioinformatics 8: 25.
35. Lüllmann H, Mohr K, Hein L, Bieger D (2005) Color Atlas of Pharmacology. p. 402.
36. Rowland M, Tozer TN (2011) Clinical Pharmacokinetics and Pharmacodynamics: Concepts and Applications. p. 864.
37. King AE, Ackley MA, Cass CE, Young JD, Baldwin SA, (2006) Nucleoside transporters: from scavengers to novel therapeutic targets. Trends Pharmacol Sci 27: 416-425.
38. Thompson AJ, Duke RK, Lummis SC, (2011) Binding sites for bilobalide, diltiazem, ginkgolide, and picrotoxinin at the 5-HT3 receptor. Mol Pharmacol. 80: 183-190.